Overview of GMP Fundamentals in Biotech and Pharma Facility Design
GMP or Good Manufacturing Practice regulations for pharmaceutical and biotechnology facility design are crucial to ensure manufactured product quality, patient safety, and compliance with regulatory standards. In the UK, these regulations are guided by the Medicines and Healthcare products Regulatory Agency (MHRA) and align with EU GMP guidelines.
The term cGMP means current Good Manufacturing Practices where guidelines are updated to current evolution.
Medicinal drugs undergo a long process (up to 15 years) from discovery, development to manufacturing before becoming available on market for patient usage. As the initial phases of discovery and development are exploratory and go through numerous iterations and testing, the regulatory pressure for product safety and efficacy is minimal. Typically, these stages are called research and development (R&D) and are carried out in synthesis, analysis and small scale-up labs.
Once drugs pass the initial hurdles and prove effective in sought after therapeutic areas, they are manufactured and prescribed to patients. This is where GMP regulations come in to play. By adhering to the regulations, regulatory bodies ensure that the particular drug is made consistently, safely and effectively across the board.
The facilities required to manufacture drug candidates need to be designed and approved by MHRA. Along with medicines, medical devices, cosmetics or food products may need GMP compliant facilities (although requirements may be somewhat different).
Here’s an overview of key considerations in facility design under UK GMP regulations:
1. Regulatory Framework
MHRA Standards: The MHRA inspects facilities to ensure compliance with EU GMP guidelines.
EudraLex Volume 4: EU GMP Annexes (e.g., Annex 1 for sterile manufacturing) are key references for designing facilities.
ISO Standards: ISO 14644 is critical for cleanroom classifications and air cleanliness.
2. General Facility Requirements
Segregation: Clear separation of areas for manufacturing, quality control, packaging, and storage to prevent cross-contamination.
Material and Personnel Flow: Proper routes for raw materials, intermediates, finished products, and personnel to minimize contamination risks.
Access Control: Restricted access to critical areas to authorised personnel only.
Space Optimization: Sufficient space for equipment, operations, and personnel movement.
3. Cleanroom Design
Each manufacturing operation requires a specific environmental cleanliness level to minimize risks of particulate or microbial contamination of products or materials.
Cleanroom Grades: The “in operation” and “at rest” states should be defined for each zone. Four grades are specified for sterile medicinal product manufacturing:
- Grade A: The cleanest, used for sterile operations with uni-directional airflow and lower velocities, often in closed isolators or glove boxes.
- Grade B: Background environment for Grade A, used for aseptic preparation and filling.
- Grade C & D: Clean areas for less critical stages in sterile product manufacturing.
Air Handling Systems (HVAC):
- Maintain appropriate cleanliness classifications (e.g., ISO 5, ISO 7).
- Positive pressure differentials to prevent contamination.
- HEPA filters for air purification.
Environmental Monitoring:
- Continuous monitoring of temperature, humidity, and particle counts.
- Alarm systems for deviations.
Surfaces and Finishes:
- Smooth, non-porous, and easy-to-clean walls, floors, and ceilings
- Avoidance of ledges or surfaces where contaminants can accumulate.
- Material of Construction: Use non-shedding, easily cleanable surfaces (e.g., stainless steel, epoxy flooring).
4. Sterility and Contamination Control
Annex 1 (Sterile Products):
- Specific guidance on sterile manufacturing, including isolators, cleanrooms, and Restricted Access Barrier Systems (RABS).
Cross-Contamination Prevention:
- Dedicated facilities for high-risk products (e.g., penicillin).
- Use of Closed Processing Systems when possible.
5. Utilities and Equipment
Water Systems:
- Design of Purified Water (PW), Water for Injection (WFI), and Clean Steam systems to minimise microbial growth and ensure compliance with pharmacopoeial standards.
Instrumentation and Automation:
- Use of compliant computerised systems (aligned with GAMP 5 guidelines).
- Use of Closed Processing Systems when possible.
6. Quality Assurance in Facility Design
Validation and Qualification:
- Facility and equipment must undergo Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).
Risk Assessment:
- Application of Quality Risk Management (QRM) principles as per ICH (International Council for Harmonisation) Q9.
- Identification of critical control points in the design phase.
7. Storage and Warehousing
Temperature and Humidity Control:
- Design storage areas for ambient, refrigerated, and frozen products.
- Monitoring systems for storage conditions.
Segregation:
- Areas for quarantine, rejected materials, and released products.
- Separate storage for hazardous and sensitive materials.
8. Documentation and Compliance
Standard Operating Procedures (SOPs):
- Detailed SOPs for facility operations, cleaning, and maintenance.
Change Control:
- Any facility modifications must go through a controlled process with risk assessments and approvals.
9. Sustainability Considerations
- Energy Efficiency: Optimise HVAC systems and lighting.
- Waste Management: Design for safe handling and disposal of biohazard and chemical waste.
- Green Building Practices: Use sustainable materials and integrate renewable energy where feasible.
10. Risk Management
- Contamination Control: Risk assessment for microbial, cross-product, and particulate contamination.
- Redundancy and Contingency: Redundant systems for utilities and critical operations.
- Fail-Safe Mechanisms: Alarms and automated shutdown systems for deviations.
By adhering to these GMP guidelines, pharmaceutical and biotechnology facilities in the UK can ensure compliance, maintain product integrity, and support patient safety. For more detailed or case-specific advice, consulting MHRA guidance documents or a GMP expert is recommended.
At Bulb Laboratories, our experienced scientific team is dedicated to understanding your processes, interpreting regulatory requirements, and designing your GMP facility while meeting all critical criteria. To ensure seamless validation and qualification, we meticulously document and provide all necessary paperwork, giving you complete peace of mind.
